Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Long-term treatment with long-acting risperidone in Korean patients with schizophrenia

Authors
Lee, Moon-SooKo, Young-HoonLee, Sang-HoonSeo, Yong-JinKim, Seung-HyunJoe, Sook-Haenghan, Cg-Su HanLee, Jung-HoJung, In-Kwa
Issue Date
8월-2006
Publisher
JOHN WILEY & SONS LTD
Keywords
long-acting injection risperidone; PANSS; schizophrenia; perceived functioning; well-being
Citation
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, v.21, no.6, pp.399 - 407
Indexed
SCIE
SCOPUS
Journal Title
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
Volume
21
Number
6
Start Page
399
End Page
407
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/123123
DOI
10.1002/hup.782
ISSN
0885-6222
Abstract
Objectives We evaluated the efficacy and safety of long-acting risperidone for 48-week period in Korean patients. Methods This was a non-randomized, open-label, single-centered, 48-week study. Each of the participants visited the hospital every 2 weeks, and injections were given at each visit. Complete evaluations were done on five occasions (baseline, 12, 24, 36, 48 weeks). We used Clinical Global Impression, Positive and Negative Syndrome Scale, Global Assessment of Functioning, Subjective Well-being under Neuroleptic treatment scale and Short-form-36 health survey. Drug attitude inventory and Drug Induced Extra-Pyramidal Symptoms Scale were also used. Results Forty patients were enrolled, and twenty-five patients completed this study. The therapeutic response rate was 36.1% in LOCF and 48% in completer's analysis. Scores on CGI, PANSS subscales and total were significantly decreased over 48-week period. Scores on other assessments did not show any significant changes over the period. At weeks 48, there was no significant difference in the changes of scores from baseline on self-rated assessments between the clinical improvement and non-improvement groups. Conclusions Our study showed significant improvement of investigator-rated psychiatric symptoms in long-term follow-up using long-acting risperidone. Further researches would be required to find out the effects of the psychiatric symptom improvements on overall changes in perceived functioning and well-being. Copyright (c) 2006 John Wiley & Sons, Ltd.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE